Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487...

FDA Device Recall #Z-2054-2016 — Class II — November 16, 2015

Recall Summary

Recall Number Z-2054-2016
Classification Class II — Moderate risk
Date Initiated November 16, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Nephron Pharmaceuticals Corp.
Location Orlando, FL
Product Type Devices
Quantity 13,692 cartons

Product Description

Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer

Reason for Recall

Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.

Distribution Pattern

Worldwide Distribution - US including AL, AR, AZ, CA, CO, CT, FL, GA, IL, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TN, TX, UT, VA, VT, WA, WI, WV and Internationally to Canada.

Lot / Code Information

Lot Number N4753A, Exp 11/16

Other Recalls from Nephron Pharmaceuticals Corp.

Recall # Classification Product Date
Z-2053-2016 Class II Sodium Chloride Inhalation Solution, USP 3%, 60... Nov 16, 2015
Z-1373-2013 Class I EZ Breathe Medication Cup. For the delivery ... Apr 30, 2013
Z-1371-2013 Class I EZ Breathe Atomizer Model # EZ-100. For the... Apr 30, 2013
Z-1372-2013 Class I AsthmaNefrin Starter Kit contains ten (10) Asth... Apr 30, 2013

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.